MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹477 Cr | ₹390 Cr | ₹341 Cr | ₹380 Cr | ₹299 Cr |
What is the latest Total Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹477 Cr |
| Mar2024 | ₹390 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹380 Cr |
| Mar2021 | ₹299 Cr |
How is Total Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹477 Cr | 22.44 | |
| Mar2024 | ₹390 Cr | 14.33 | |
| Mar2023 | ₹341 Cr | -10.29 | |
| Mar2022 | ₹380 Cr | 27.13 | |
| Mar2021 | ₹299 Cr | - | |
Compare Total Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹11,155.5 Cr | 16.3% | 33.4% | 0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 16.3% |
33.4% |
0.9% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses